YU3701A - Supstituisani fenilamidini sa antitrombskim dejstvom - Google Patents

Supstituisani fenilamidini sa antitrombskim dejstvom

Info

Publication number
YU3701A
YU3701A YU3701A YU3701A YU3701A YU 3701 A YU3701 A YU 3701A YU 3701 A YU3701 A YU 3701A YU 3701 A YU3701 A YU 3701A YU 3701 A YU3701 A YU 3701A
Authority
YU
Yugoslavia
Prior art keywords
phenylamidines
antithrombotic action
relates
substituted phenylamidines
substituted
Prior art date
Application number
YU3701A
Other languages
English (en)
Inventor
Frank Himmesbasch
Brian Guth
Hans-Dieter Schubert
Original Assignee
Boehringer Ingelheim Pharma Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg. filed Critical Boehringer Ingelheim Pharma Kg.
Publication of YU3701A publication Critical patent/YU3701A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/49—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton
    • C07C211/50—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton with at least two amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Pronalazak se odnosi na fenilamidine, opšte formule (I), u kojoj su R6 i R7 definisani kao u zahtevu 1, na njihove teutomere, njihove stereoizomere, uključujući njihove smeše i njihove soli, naročito njihove fiziološki podnošljive soli sa neorganskim ili organskim kiselinama ili bazama, koji imaju dragocena farmakološka svojstva, prvenstveno antitrombsko dejstvo, na lekove koji sadrže ova jedinjenja, na njihovu primenu i postupak za njihovo pripremanje.[The invention relates to phenylamidines of formula (I), in which R6 and R7 are defined as described in claim 1, their tautomers and their stereoisomers, including their mixtures and salts, especially physiologically compatible salts with inorganic or organic acids and bases, which have valuable pharmacological properties, preferably antithrombotic effects. The invention also relates to medicaments containing said compounds, to their use and to methods for preparing same.
YU3701A 1998-07-23 1999-07-20 Supstituisani fenilamidini sa antitrombskim dejstvom YU3701A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833105A DE19833105A1 (de) 1998-07-23 1998-07-23 Substituierte Phenylamidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
YU3701A true YU3701A (sh) 2003-01-31

Family

ID=7875009

Family Applications (1)

Application Number Title Priority Date Filing Date
YU3701A YU3701A (sh) 1998-07-23 1999-07-20 Supstituisani fenilamidini sa antitrombskim dejstvom

Country Status (30)

Country Link
EP (1) EP1102746B1 (sh)
JP (1) JP3629208B2 (sh)
KR (1) KR20010072046A (sh)
CN (1) CN1310708A (sh)
AR (1) AR019462A1 (sh)
AT (1) ATE240297T1 (sh)
AU (1) AU5285399A (sh)
BG (1) BG105159A (sh)
BR (1) BR9912321A (sh)
CA (1) CA2337413A1 (sh)
CO (1) CO5080745A1 (sh)
DE (2) DE19833105A1 (sh)
DK (1) DK1102746T3 (sh)
EA (1) EA200100106A1 (sh)
EE (1) EE200100048A (sh)
ES (1) ES2199587T3 (sh)
HK (1) HK1038750A1 (sh)
HU (1) HUP0103327A3 (sh)
ID (1) ID27205A (sh)
IL (1) IL140774A0 (sh)
NO (1) NO20010354L (sh)
PL (1) PL345624A1 (sh)
PT (1) PT1102746E (sh)
SK (1) SK1052001A3 (sh)
TR (1) TR200100182T2 (sh)
TW (1) TW460461B (sh)
UY (1) UY25621A1 (sh)
WO (1) WO2000005207A1 (sh)
YU (1) YU3701A (sh)
ZA (1) ZA200100363B (sh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10002510A1 (de) 2000-01-21 2001-07-26 Boehringer Ingelheim Pharma Substituierte Phenylamidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US8399678B2 (en) * 2009-11-18 2013-03-19 Boehringer Ingelheim International Gmbh Process for the manufacture of dabigatran etexilate
EP2522662A1 (en) * 2011-05-11 2012-11-14 Medichem, S.A. Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers
CN105330568B (zh) * 2015-11-27 2017-05-10 山东省医学科学院药物研究所 一种对氨基苯甲脒盐酸盐的制备方法
CN105732433A (zh) * 2016-04-13 2016-07-06 山东新华制药股份有限公司 达比加群酯中间体缩合物的精制方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1170409A (zh) * 1994-12-01 1998-01-14 富山化学工业株式会社 新的2,3－二氧代哌嗪衍生物及其盐
DE19515500A1 (de) * 1995-04-27 1996-10-31 Thomae Gmbh Dr K Substituierte Phenylamidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
CA2337413A1 (en) 2000-02-03
PL345624A1 (en) 2002-01-02
BR9912321A (pt) 2001-04-24
DE19833105A1 (de) 2000-01-27
NO20010354D0 (no) 2001-01-22
ID27205A (id) 2001-03-08
KR20010072046A (ko) 2001-07-31
ZA200100363B (en) 2001-07-18
ES2199587T3 (es) 2004-02-16
CN1310708A (zh) 2001-08-29
DK1102746T3 (da) 2003-09-08
HUP0103327A3 (en) 2003-11-28
JP3629208B2 (ja) 2005-03-16
EE200100048A (et) 2002-06-17
ATE240297T1 (de) 2003-05-15
CO5080745A1 (es) 2001-09-25
AR019462A1 (es) 2002-02-20
JP2002521363A (ja) 2002-07-16
DE59905568D1 (de) 2003-06-18
PT1102746E (pt) 2003-10-31
HK1038750A1 (zh) 2002-03-28
IL140774A0 (en) 2002-02-10
AU5285399A (en) 2000-02-14
BG105159A (bg) 2001-07-31
TW460461B (en) 2001-10-21
EA200100106A1 (ru) 2001-08-27
TR200100182T2 (tr) 2001-07-23
EP1102746B1 (de) 2003-05-14
NO20010354L (no) 2001-01-22
SK1052001A3 (en) 2001-08-06
UY25621A1 (es) 2001-12-28
HUP0103327A2 (hu) 2002-01-28
EP1102746A1 (de) 2001-05-30
WO2000005207A1 (de) 2000-02-03

Similar Documents

Publication Publication Date Title
NO933248L (no) Cykliske urinstoffderivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling
TR199900920T2 (xx) Nafthiridin t�revleri.
CA2244785A1 (en) Pentafluorobenzenesulfonamides and analogs
YU50002A (sh) Supstituisani piperidini, lekovi koji sadrže ova jedinjenja i postupci za njihovu proizvodnju
NO972881L (no) Piperazinderivater, legemidler som inneholder disse, anvendelse derav og fremgangsmåte for deres fremstilling
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
NO940261L (no) 5-leddete heterocykler, fremgangsmåte ved fremstilling derav og legemidler som inneholder disse forbindelser
MXPA00012819A (es) Bencimidazoles, su preparacion y su empleo como medicamentos.
BG103947A (en) Derivatives of 9-oxymerythromycin
DE69627035D1 (de) Derivate von aminosäuren, sie enthaltende pharmazeutische zusammensetzungen sowie deren herstellunsgverfahren
AP9701041A0 (en) Pyridylpyrrole compounds.
MX9700020A (es) Derivados ciclicos de una urea, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
YU60900A (sh) Novi kristalni oblici antivirusnog benzimidazolskog jedinjenja
YU30902A (sh) Novi ciklopropani kao cgrp antagonisti, lekovi koji sadrže navedena jedinjenja i postupak za njihovu proizvodnju
GEP20033081B (en) Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas
NZ300942A (en) 1-aryl-2-acylamino-ethane derivatives as neurokinin 1 antagonists
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
YU3701A (sh) Supstituisani fenilamidini sa antitrombskim dejstvom
YU19302A (sh) 4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena
AU5500896A (en) Substituted phenylamidines, pharmaceutical compositions containing these compounds and processes for preparing them
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
GR3033583T3 (en) Anticoagulant peptide aldehyde derivatives
NZ229300A (en) Substituted-2-ethenyl-3,4,5,6-tetrahydrothieno (4,3,2-cf)(3)benzazepine derivatives and pharmaceutical compositions
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine
WO2000018732A3 (de) Disubstituierte pyrrolidinone, diese verbindungen enthaltende arzneimittel und deren verwendung sowie ihre herstellung